Stanbik Agro (544659)

Score breakdown: P/E: 2/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• P/E of 12.07 is not demanding, implying a moderate earnings yield if the reported earnings are sustainable.
• ROCE of 45.43% suggests strong capital efficiency in the underlying business, if operations are genuine.
• Small market cap of ₹45 Cr and price of ₹33.88 make it a niche micro-cap that could offer outsized recovery returns.

Concerns

• Latest quarter shows sales of ₹0 Cr and net profit of ₹0 Cr, indicating the business may be dormant or operations have halted.
• Sales growth and profit growth are both 0.00%, with no organic expansion or compounding visible.
• Piotroski F-Score of 3/9 signals weak financial health and fundamental fragility.
• Zero dividend yield, no book value, no debt/equity, and no promoter holding data create a serious lack of transparency.

AI Analysis

Stanbik Agro is precisely the kind of situation that demands extra caution. At ₹33.88, market cap ₹45 crore, the trailing P/E of 12.07 looks interesting on the surface, implying an earnings yield close to 8%. But Graham taught us never to trust a single ratio without understanding the business and its financial statements. Here the latest quarter shows sales of ₹0 crore and net profit of ₹0 crore. That is a glaring contradiction. Either the business is seasonal to an extreme degree, or operations have stopped. With no sales or profit growth — both 0.00% — and no dividend, this is not a compounding machine. The only bright spot is ROCE of 45.43%, which would be wonderful if genuine and sustainable, yet a Piotroski F-score of 3/9 warns of weak fundamental health. I have no book value, no debt/equity, and no promoter holding, so I cannot calculate a margin of safety. I cannot value what I cannot see. The stock may be cheap, but in the words of Buffett, it is far better to buy a wonderful company at a fair price than a fair company at a wonderful price. This company lacks the consistent earnings history, transparent balance sheet, and clear moat that I demand. Absent hard evidence of revived operations, the low P/E is a value trap, not an opportunity. I would keep it on the watchlist and require several quarters of genuine revenue and profit before considering any investment. The price may eventually be justified by future recovery, but that is a speculative turnaround, not an investing decision.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer